ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,986.03
-0.78%
US Tech 100
21,248.40
-0.58%
Dow Jones
42,235.15
-0.66%
Brent Oil
75.01
4.53%
Bitcoin
103,899.70
-2.67%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Jasper Therapeutics Inc (JSPRW) Quote

Jasper Therapeutics Inc

Jasper Therapeutics Inc (JSPRW)

NASDAQ
0.138
-0.0069
( -4.76% )
Updated: 11:43:02
15 min delayed - Upgrade to Realtime

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.138
Bid
0.0771
Ask
0.1397
Volume
2,813
0.0771 Day's Range 0.1397
0.0605 52 Week Range 0.2526
Market Cap
2.073M
Previous Close
0.144899
Open
0.0771
Last Trade
179
@
0.138
Last Trade Time
11:41:58
Financial Volume
$ 315
VWAP
0.112024
Average Volume (3m)
3,967
Shares Outstanding
15,022,122
Dividend Yield
-
PE Ratio
-1.17
Earnings Per Share (EPS)
-4.74
Revenue
-
Net Profit
-71.27M

About Jasper Therapeutics Inc

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem ce... Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.jaspertherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Jasper Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker JSPRW. The last closing price for Jasper Therapeutics was $0.14. Over the last year, Jasper Therapeutics shares have traded in a share price range of $ 0.0605 to $ 0.2526.

Jasper Therapeutics currently has 15,022,122 shares outstanding. The market capitalization of Jasper Therapeutics is $2.18 million. Jasper Therapeutics has a price to earnings ratio (PE ratio) of -1.17.

Ask ADVFN Intelligence (AI)

JSPRW Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 16 2025
JSPRW (-4.76%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
JSPRW (-4.76%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
JSPRW (-4.76%)

Form 8-K - Current report
Edgar (US Regulatory)
May 12 2025
JSPRW (-4.76%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 12 2025
JSPRW (-4.76%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
March 27 2025
JSPRW (-4.76%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
March 26 2025
JSPRW (-4.76%)

Form 8-K - Current report
Edgar (US Regulatory)
March 19 2025
JSPRW (-4.76%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
March 19 2025
JSPRW (-4.76%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
February 28 2025
JSPRW (-4.76%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.018150.120.17750.0681145410.14133192CS
40.05510166.46762928380.0828990.17750.068166260.1234608CS
12-0.005-3.49650349650.1430.17750.060539670.11227635CS
26-0.084-37.83783783780.2220.230.060549020.14081476CS
52-0.082-37.27272727270.220.25260.060542680.16787665CS
1560.0086.153846153850.130.38180.016175120.12944712CS
260-1.592-92.02312138731.732.240.016189480.49946098CS

JSPRW - Frequently Asked Questions (FAQ)

What is the current Jasper Therapeutics share price?
The current share price of Jasper Therapeutics is $ 0.138
How many Jasper Therapeutics shares are in issue?
Jasper Therapeutics has 15,022,122 shares in issue
What is the market cap of Jasper Therapeutics?
The market capitalisation of Jasper Therapeutics is USD 2.18M
What is the 1 year trading range for Jasper Therapeutics share price?
Jasper Therapeutics has traded in the range of $ 0.0605 to $ 0.2526 during the past year
What is the PE ratio of Jasper Therapeutics?
The price to earnings ratio of Jasper Therapeutics is -1.17
What is the reporting currency for Jasper Therapeutics?
Jasper Therapeutics reports financial results in USD
What is the latest annual profit for Jasper Therapeutics?
The latest annual profit of Jasper Therapeutics is USD -71.27M
What is the registered address of Jasper Therapeutics?
The registered address for Jasper Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Jasper Therapeutics website address?
The website address for Jasper Therapeutics is www.jaspertherapeutics.com
Which industry sector does Jasper Therapeutics operate in?
Jasper Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CEROCERo Therapeutics Holdings Inc
$ 24.6399
(258.76%)
49.56M
ACXPAcurx Pharmaceuticals Inc
$ 0.707
(130.22%)
295.15M
RBNERobin Energy Ltd
$ 11.8501
(114.68%)
35.89M
VERVVerve Therapeutics Inc
$ 11.225
(79.03%)
72.42M
INEOINNEOVA Holdings Ltd
$ 1.82
(63.96%)
18.59M
SDSTStardust Power Inc
$ 0.1917
(-50.63%)
33.46M
SHOTWSafety Shot Inc
$ 0.015
(-49.66%)
6.45k
RUNSunrun Inc
$ 5.97
(-38.07%)
93.55M
SEDGSolarEdge Technologies Inc
$ 15.92
(-33.61%)
27.25M
ADILAdial Pharmaceuticals Inc
$ 0.2411
(-25.84%)
5.65M
PCSAProcessa Pharmaceuticals Inc
$ 0.2704
(20.12%)
541.73M
ACXPAcurx Pharmaceuticals Inc
$ 0.707
(130.22%)
295.21M
GNLNGreenlane Holdings Inc
$ 0.0103
(-16.94%)
278.32M
HCTIHealthcare Triangle Inc
$ 0.0211
(-20.08%)
242.55M
LCIDLucid Group Inc
$ 2.1698
(0.92%)
115.97M

Discussion

View Full Feed
sab63090 sab63090 1 minute ago
Gary,
Thanks but I'm pretty comfortable with the support I get from LLS.org and my oncologist. Hope you are well taken care of! Steve
AVXL
Doubledown75 Doubledown75 1 minute ago
Should be at least double zeros BMXI is at 2.5 cents and it has eps of 4 cents. Both should be trading a lot higher. Still in the trips EZ $$$
BMXI
PickStocks PickStocks 2 minutes ago
You are thinking Cactus signed an NDA????
COOP
RedShoulder RedShoulder 2 minutes ago
Many Thanks vg_future for posting this important FDA related find.

If that was applied to AVXL's NDA entry into the FDA relatively soon, it could possibly parallel the EMA approval.

..."The U.S. Food and Drug Administration today announced its Commissioner’s National P
AVXL
Lone Clone Lone Clone 2 minutes ago
Vanguard Mining Finalizes Acquisition of Strategic 90,000 ha Uranium Project Adjacent to UEC's 8.96M-lb Yuty Deposit in Paraguay

https://thenewswire.com/press-releases/1LYzFb4Xl-vanguard-mining-finalizes-acquisition-of-strategic-90-000-ha-uranium-project-adjacent-to-uec-s-8-96m-lb-yut
ThoroughBread ThoroughBread 2 minutes ago
Ignore them. Just deadbeats without purpose in life, they come at a dime a dozen
SONG
ducci1 ducci1 2 minutes ago
VIX---Day # 5 above 15 min Red Line--Bears Above-----VIX Fib at 21.41 LITS ??
VIX
underpar71 underpar71 2 minutes ago
That would be even better if they had a provision of date of ownership and a way to determine legal ownership and account for all legitimate shares....leaving the naked shorts to have to cover now rather than after three more years of litigation.
NWBO
ErnieBilco ErnieBilco 2 minutes ago
Using the original exercise price of $6 it would be 4,166,667* warrants for A and another 4,1661667* for B and 8,333,333* for Tranche C

* it take 4/5 of a warrant per common so the numbers may be a little higher than above

This is assuming they did not lower the exercis
UNCY
JW62 JW62 3 minutes ago
I Respect the honesty but very unrealistic there has been at least bi weekly updates by management, fully up to date and now on Canadian side fully active, also we have hit a quadruple bottom now with support above .0027 and now higher even after both of the last selloffs due to people like you but
TWOH
22rover 22rover 3 minutes ago
Always appreciate your input, vCiso. From my perch, I actually don’t see much resistance until .18, where the private placement took place. The sellers have had 3 years to sell, while the company built a soon-to-be profitable company. And *sell* they did. Probably to the tune of 20-30 million shar
SDCH
TheHappyVulcan TheHappyVulcan 3 minutes ago
Gizzer, you've a valid point. Everyone has differing strategies, different thresholds, different socks . There is no point getting icky about something as banal as stock trading .
Holding back unbridled emotion always Is a smarter choice. Being polite is always a win for all Involved.
BBUZ
excelsiorvision excelsiorvision 3 minutes ago
Over 113 million shares traded so far today and nearly 10% of the OS. Assume follow ups to the PR are coming very soon too. Based on the revenue they'd generate from these JVs, BIEI should be trading in the pennies soon with no PE. With a small PE ratio, it will would be in silver.
BIEI
budfoxfun budfoxfun 3 minutes ago
$ZENA ZenaTech launched the ZenaDrone IQ Nano, a compact, autonomous indoor drone for the US Department of Defense and government agencies https://x.com/ZenatechInc/status/1935011634977591527
ZENA
okwife okwife 3 minutes ago
in what country ??
PSRU
1jas 1jas 3 minutes ago
you do, good work chart master.
AFFU
Top Penny Top Penny 4 minutes ago
I smell something coming and shorty knows it's all but too late to stop it!!!! Damage control time LMFAO!!!
PSRU
georgie18 georgie18 5 minutes ago
Don't you have anything good to say...🥳...It's not imploding...
breynolds breynolds 5 minutes ago
A couple big slaps on the ask and it'll fall fast!!!
GTCH
MightyX MightyX 5 minutes ago
Anybody else more than double position under $8?
TPTW
plexrec plexrec 5 minutes ago
vg---".could help Anavex"--great find---hoping Anavex is familiar with this and could benefit--in getting FDA approval !!!!!
AVXL
mdb1 mdb1 6 minutes ago
The $9s are coming .. the $9s are coming.
IQST
Spike5 Spike5 6 minutes ago
This is not moving anywhere except to a reverse split . And then it will fade away to nothing. This company had every opportunity to succeed. Not at a 100 dollars but it should have at least been 10 dollars. Management went out of their way to suppress this stock and i am not sure i will ever know
GERN
RammageRaul RammageRaul 6 minutes ago
Kaboom 0005
PSWW
PSWW
linkvest linkvest 6 minutes ago
197,410,878 on the ASK.. LMAO... I guarantee most is nothing more than air fake wall shares in trying to get those 2s. No way in hell does dudes want to sell any of their 3s this cheap. Some two tick flips maybe but the chances of buying this cheap might never happen again and they know they could l
GTCH

Your Recent History

NASDAQ
JSPRW
Jasper Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads